Charles River Laboratories International (MIL:1CRL) Total Equity: €2,585 Mil (As of Mar. 2026)


MIL:1CRL Charles River Laboratories International Inc MIL:1CRL
70 GF Score
Price €143.90
GF Value €121.29
! 8 Warning Signs
View Full Analysis

What is Charles River Laboratories International Total Equity?

Charles River Laboratories International MIL:1CRL 70 Total Equity is €2,585 Mil as of Mar. 2026. GuruFocus rates MIL:1CRL with a GF Score™ of 70/100 and a GF Value™ of €121.29. The stock has 8 warning signs investors should review.

Charles River Laboratories International's total equity for the quarter that ended in Mar. 2026 was €2,585 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Charles River Laboratories International Total Equity Historical Data

* Premium members only.

The historical data trend for Charles River Laboratories International's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Charles River Laboratories International Total Equity Chart

Charles River Laboratories International Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,293.91 2,854.19 3,355.30 3,350.21 2,742.36

Charles River Laboratories International Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,998.65 2,947.44 2,940.10 2,742.36 2,584.89
MIL:1CRL
70GF Score
Charles River Laboratories International Inc MIL:1CRL
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Charles River Laboratories International Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Charles River Laboratories International's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=6093.65-3351.291
=2,742

Charles River Laboratories International's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=6686.716-4101.826
=2,585

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of €2,585 Mil mean?
Charles River Laboratories International (MIL:1CRL) has a Total Equity of €2,585 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Charles River Laboratories International and its competitors.
Is Charles River Laboratories International's Total Equity too high?
Charles River Laboratories International's current Total Equity is €2,585 Mil. Overall, Charles River Laboratories International has a GF Score™ of 70/100, reflecting its overall financial health beyond just this single metric.
How does Charles River Laboratories International's Total Equity compare to RVTY and QGEN?
Charles River Laboratories International's Total Equity of €2,585 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Diagnostics & Research company?
A good Total Equity depends on the Medical Diagnostics & Research industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Charles River Laboratories International and its competitors. Charles River Laboratories International's current Total Equity is €2,585 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Charles River Laboratories International stock overvalued right now?
Charles River Laboratories International (MIL:1CRL) has a current Total Equity of €2,585 Mil. The stock's GF Value™ is €121.29, compared to a current price of €143.90 — trading 18.6% above its estimated fair value. The current Total Equity is €2,585 Mil. Charles River Laboratories International's overall GF Score™ is 70/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Charles River Laboratories International (MIL:1CRL), the current Total Equity is €2,585 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Charles River Laboratories International (MIL:1CRL) Overvalued in 2026?

Based on GuruFocus' analysis, Charles River Laboratories International stock appears to be overvalued. The current stock price of €143.90 is trading 18.6% above its estimated GF Value™ of €121.29.

Key valuation signals for MIL:1CRL:

  • Total Equity: €2,585 Mil
  • GF Value™: €121.29 vs. price of €143.90 (18.6% above fair value)
  • GF Score™: 70/100 with 8 warning signs

No single metric tells the full story. See the MIL:1CRL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Charles River Laboratories International Business Description

Other Exchanges CRL:USARV6:Germany
Address 251 Ballardvale Street, Wilmington, MA, USA, 01887
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
70GF Score

Get the complete analysis for MIL:1CRL

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€143.90
Price
€121.29
GF Value